13 C-labeled pyruvate studies with magnetic resonance (MR) have been used to observe the kinetics of metabolism in vivo. Kinetic modeling to measure metabolic rates in vivo is currently limited because of nonspecific hyperpolarized signals mixing between vascular, extravascular, and intracellular compartments. In this study, simultaneous acquisition of both 1 H and 13 C signals after contrast agent injection is used to resolve specific compartments to improve the accuracy of the modeling. We demonstrate a novel technique to provide contrast to the intracellular compartments by sequential injection of HP [1-13 C] pyruvate followed by gadolinium-chelate to provide T 1 -shortening to extra-cellular compartments. A kinetic model that distinguishes the intracellular space and includes the T 1 -shortening effect of the gadolinium chelate can then be used to directly measure the intracellular 13 C kinetics.
I. INTRODUCTION
A DVANCES in speed and sensitivity of medical imaging modalities such as MRI have made it possible to perform a wide range of functional measures in vivo using modeling. One promising technique that has emerged uses hyperpolarized (HP) 13 C-labeled pyruvate and other metabolites with magnetic resonance (MR) to observe metabolism in order to determine the relative rates of metabolite production in healthy and diseased tissues, most notably cancer. No other imaging technology is capable of similar sensitivity for measuring dynamic in vivo metabolism.
In the majority of studies, qualitative ratios, such as lactate to pyruvate peak ratio [1] - [3] , have been used instead of precise quantitative measures of intracellular lactate production from intracellular pyruvate substrate. More recently, simplified models have yielded estimates of metabolic rate constants that indicate a response to treatment [4] , [5] . These rates, however, reflect not only intracellular chemical exchange but also membrane transport and pyruvate delivery outside the cell and within the vasculature because of the lack of any contrast between these compartments. In cell culture, Harris et al. [6] removed the extracellular space through flushing the bioreactor with a perfusion system leaving cells and their intracellular compartments unchanged. Results indicated that label flux estimated with kinetic modeling in T47D cells is chiefly determined by cellular uptake via monocarboxylate transporters. Techniques to provide contrast between functional compartments in vivo include frequency shift agents [7] , or suppression of flowing spins in the vasculature using stimulated echoes [8] . However, these methods are limited because of high cytotoxicity or because of limited effect at the scale of the organ tissues where cellular measures of metabolism occur.
To separate membrane transport dynamics and intracellular chemical exchange, we present a technique to eliminate the 13 C signal within specific compartments by following the injection of HP [1- 13 C] pyruvate with an injection of a T 1 -shortening contrast agent (CA). Using a widely used two-compartment model [4] , we show this sequential injection technique avoids an underestimation of the metabolic rate constants by eliminating the relatively large 13 C vascular signal in application to healthy rat brain metabolism. Moreover, simultaneous 1 H and 13 C MRI enables coincident measurement of the CA concentration from the 1 H signal to constrain the modeling of the [1-13 C] pyruvate metabolism.
II. METHODS AND MATERIALS
A. Hyperpolarized [1- 13 C] Pyruvate
The process of dynamic nuclear polarization has been reported previously [9] , [10] . Briefly, 30 μL of 14.2 M [1-
13 C] pyruvic acid is doped with 15-mM trityl radical (OX63) [9] and inserted into a HyperSense polarizer (Oxford Instruments, Tubney Woods, Abingdon, U.K.) which provides the 3.35-T magnetic field and a temperature of 1.4 K. After reaching a solid-state polarization near 20%, rapid dissolution of the [1- 13 C] pyruvic acid is accomplished by heating a 4 mL solvent (100-mM NaOH, 100-mM Tris, and 0.43-mM EDTA) to 180
• C under high pressure. This mixture serves to both thaw and neutralize the pyruvate, making it suitable for animal injection.
B. Gadolinium as an Intracellular Contrast Agent
Gadolinium-chelated compounds are routinely injected clinically to provide tissue contrast by increasing the relaxation rate of surrounding spins during a T 1 -weighted acquisition [11] . Although increasing the relaxation rate of a hyperpolarized compound appears at first glance to be an inefficient use of the polarized signal because of the induced accelerated T 1 decay, the restricted distribution of the CA to be intravascular only in healthy brain and intra-and extravascular only in most other tissues enables more precise localization of polarized signal and allows a more accurate estimation of intracellular lactate production. Exposure to sufficient concentrations of gadolinium can, therefore, effectively eliminate all but the compartmental signal [12] without the CA in analogy to the washout experiments performed in cell-culture by Harris et al. in [6] . As such, we rely on the restricted distribution of the CA to improve the modeling accuracy of in vivo intracellular metabolism.
C. Animal Preparation
In vivo studies were performed on adult Sprague-Dawley rats (∼230 g) under protocols approved by the Institutional Animal Care and Use Committee using spectroscopy (two rats) and imaging (one rat). Anesthesia was induced with 5% isoflurane and maintained with 2%-2.5% isoflurane during the experiments. The tail vein was cannulated for intravenous injections. Animals were placed on a heated water pad (Adroit Medical Systems, Loudon, TN) to maintain a body temperature of at least 34
• C throughout the experiment. Respiratory rate and rectal temperature were monitored throughout the experiments with an MR-compatible monitoring system (SA Instruments, Inc., Stony Brook, NY).
D. MR Hardware and Methods
In a series of feasibility studies, two rats were each tested using a spectroscopy acquisition after both a [1-
13 C] pyruvate injection and after [1- 13 C] pyruvate injection with sequential CA injection. A third rat was tested using dynamic spectroscopic imaging of both 13 C and 1 H nuclei after [1-13 C] pyruvate and sequential CA injection, i.e., simultaneous multinuclear acquisition. For all experiments, a 1.2-mL sample of 100-mM hyperpolarized [1-
13 C] pyruvate was injected at a rate of 0.25 mL/s and was immediately flushed with saline to clear the injection line. In experiments using a sequential injection of CA (Omniscan, GE Healthcare, Milwaukee, WI), a dose of 0.5 mmol/kg was injected through the tail vein 20 s after the start of the pyruvate injection to coincide with the maximum signal intensity of lactate followed by a saline flush.
All measurements were performed on a 4.7-T small animal scanner with a 10-cm diameter bore (Agilent, Santa Clara, CA). For the two dynamic MR spectroscopy experiments, a small 2.2-cm diameter loop surface coil operating at 199.75 MHz for proton was placed directly on the head and used to localize and shim on the brain. This coil was then replaced with a second loop surface coil with identical dimensions operating at 50.23 MHz for the carbon acquisition. The sensitivity of the loop coil restricted the acquired signal to the brain due to its limited diameter. Dynamic spectroscopy began ∼2 s prior to the injection of the hyperpolarized [1-
13 C] pyruvate. A flip angle (approximately 8 degrees) was used to produce a free induction decay every 2 s (TR = 2 s) consisting of 800 readout points and a spectral window of 4 000 Hz. A small urea reference phantom (5 mL of 3 M, 99%
13 C enriched urea) was placed above the coil.
The dynamic MR spectroscopic imaging (MRSI) experiment used a simultaneous 13 C and 1 H acquisition with a custom built dual-tuned orthogonal double solenoid RF volume coil that was designed specifically for this application [13] . The organ of interest was the liver for this experiment, and all other aspects of the setup were the same as previously described.
E. Data Acquisition and Analysis
The resulting spectra were apodized in the time domain using a Blackman-Harris window [14] . Zero-and first-order phasing was applied by minimizing the entropy [15] using custom scripts in MATLAB (The Mathworks, Natick, MA). After normalizing the data to the maximum pyruvate signal, the peak signals were plotted over time.
The simultaneous 13 C and 1 H imaging acquisition consists of a fast 2-D radial imaging acquisition with the receiver channels and modification of the signal mixer of the scanner to demodulate separately at both the 13 C and 1 H nuclear MR frequencies [16] . This allows for an imaging sequence that acquires the same imaging volume in time and space enabling reconstruction of both a dynamic CA concentration [CA] map as well as the dynamic 13 C metabolic map.
F. Compartmental Modeling
The dynamic signals for the pyruvate and lactate peaks were fitted to a well described two-compartment model [4] that is consistent with intracellular pyruvate to lactate conversion
where L Z and P Z denote the lactate and pyruvate signals, t is the time, P ∞ and L ∞ correspond to the equilibrium signal at time ∞, k P and k L are the apparent rate constants that include T 1 decay, delivery, and membrane transport kinetics. The relaxation rates (ρ P , ρ L ) in this model are assumed to be the same for pyruvate and lactate. Both dynamic spectroscopy experiments were fit after a delay to properly account for the CA injection timing relative to the [1-
13 C] pyruvate injection. The resultant values from the model fitting were then compared to demonstrate potential differences in estimated rates of lactate production. For the brain experiments, the concentration of CA in the brain following a bolus injection was assumed based on the literature [17] for simulation, but the simultaneous acquisition described later enabled real-time measurement of local T 1 times to further improve the modeling precision.
G. Simultaneous Imaging of
1 H and 13 C
In order to directly measure the regional concentration of the CA, a simultaneous 1 H and 13 C acquisition was developed in order to provide an independent measure of the CA effect on T 1 -shortening of protons within the biological compartments. A technique to monitor the concentration of the CA in vivo using a bookend T 1 signal intensity modulation technique [11] was combined with simultaneous measurement of hyperpolarized 13 C tracer metabolism in a third rat. This dynamic multinuclear MRSI technique provides several advantages by providing complementary information in order to constrain the signal modeling.
This technique allowed a more realistic model by providing contrast to the compartments that represented the vascular and extracellular/extravascular spaces using
where [CA] is the concentration (mM) of the gadolinium contrast agent. The relaxivity r 1 of the specific CA used for [1-13 C] pyruvate was measured in separate experiments at 4.7 T and found to be 0.19 ± .01 s −1 ·mmol −1 .
III. RESULTS
A. 13 
C Acquisitions
The dynamic spectra that were acquired in the first two experiments are shown in Fig. 1(a) . The increased relaxation of the spectra after gadolinium injection is apparent compared to the spectra without the sequential CA injection. Fig. 1(b) compares the normalized pyruvate and lactate dynamics for both experiments. Following the CA injection (t = 18 s), the pyruvate signal decay rate significantly increases and the lactate signal shows a similar response. After a short time for both mixing of the circulation and spin-lattice exchange between the CA and vascular 13 C spins, qualitatively the signal decay stabilizes to a new exponential decay rate. Compartmental modeling of the two experiments (see Fig. 2 ) revealed a significant difference in the apparent metabolic rate constants. In Table I , it is noted that the apparent metabolic rate constant k P increased markedly after eliminating signal from the vascular compartment. The kinetic measures of metabolism in the liver require a more complex model due to the inclusion of an extravascular compartment in the absence of a blood-brain barrier.
B. Simultaneous 13 C and 1 H Imaging
As is seen in Fig. 3 , the simultaneous acquisition of both the hyperpolarized [1-
13 C] pyruvate as well as the 1 H signal allows for the localization of the dynamic information for both channels. This is shown in Fig. 3(a) where both the [1-
13 C] pyruvate intensity and concentration of CA are plotted together to show the extracellular depolarization of the hyperpolarized 13 C signal caused by the CA in those regions. The images in Fig. 3(a)-(b) show two stages in the dynamic time course of the experiment with the [1-
13 C] pyruvate data overlaid on the 1 H data. Fig. 3(a) shows a time point before the CA has reached the liver. Fig. 3(b) shows a time point after the CA has depolarized most of the 13 C signal in the vascular space, while the signal in the tissue remains high.
C. Modeling of Gadolinium Based on Prior Calculation
A more realistic model that distinguishes a vascular compartment is presented in Fig. 4(a) . An input function based on the literature [17] and applied to the data from the brain using this model results in good agreement between the model and data [see Fig. 4(b) ] and is hypothesized to reflect a more precise representation of the metabolite dynamics.
IV. DISCUSSION
In vivo metabolic studies using HP 13 C compounds raise significant challenges for quantitative measurement of cellular metabolism due to inadequate compartmental characterization using conventional simplified kinetic modeling methods. Therefore, alternative strategies that resolve signal from different compartments and provide additional constraints through independent measures of vascular perfusion are needed to accurately estimate both membrane transport and intracellular chemical exchange. This study demonstrates that injection of a T 1 -shortening agent following a 13 C-pyruvate injection not only provides contrast to isolate the intracellular 13 C signal in vivo, but can provide perfusion and local T 1 relaxivity information when the dynamic 1 H and 13 C signals are acquired simultaneously [16] . A potential disadvantage of Gd-chelates is Fig. 4. (a) Four-compartment model, which is an extension of the twocompartment model [4] , allows for the modeling of the increased relaxation due to a sequential CA injection within the vascular compartment. (b)Simulation of the compartment specific T 1 -shortening effect using a simulated CA input function compares well with the measured data. The inclusion of the CA into the model allows a more complete use of the data acquired.
that they accelerate decay of the polarized substrate (e.g., pyruvate). This trades off signal to noise in exchange for quantitative accuracy. This tradeoff may not always be desirable, especially if quantitative precision is not required for a given application.
Future work will investigate sensitivity to model parameters and different concentrations and relaxivities of CA and to extend the modeling to body organs such as the liver where the extravascular compartment must be considered. Another important avenue for future research is to include other T 1 -shortening contrast agents with different but known volumes of distribution for applications in healthy and diseased models.
